Under physiological conditions the gut-associated lymphoid tissues not only prevent the induction of a local inflammatory immune response, but also induce systemic tolerance to fed antigens 1, 2 . A notable exception is coeliac disease, where genetically susceptible individuals expressing human leukocyte antigen (HLA) HLA-DQ2 or HLA-DQ8 molecules develop inflammatory T-cell and antibody responses against dietary gluten, a protein present in wheat 3 . The mechanisms underlying this dysregulated mucosal immune response to a soluble antigen have not been identified. Retinoic acid, a metabolite of vitamin A, has been shown to have a critical role in the induction of intestinal regulatory responses [4] [5] [6] . Here we find in mice that in conjunction with IL-15, a cytokine greatly upregulated in the gut of coeliac disease patients 3, 7 , retinoic acid rapidly activates dendritic cells to induce JNK (also known as MAPK8) phosphorylation and release the proinflammatory cytokines IL-12p70 and IL-23. As a result, in a stressed intestinal environment, retinoic acid acted as an adjuvant that promoted rather than prevented inflammatory cellular and humoral responses to fed antigen. Altogether, these findings reveal an unexpected role for retinoic acid and IL-15 in the abrogation of tolerance to dietary antigens.
Induction of regulatory intestinal responses to oral antigens prevents the subsequent development of systemic T-helper type-1 (T H 1) responses to those antigens, a phenomenon referred to as oral tolerance 2 . An exception to this is coeliac disease, where patients mount a T H 1 immune response to dietary gluten 3 . To determine whether the presence of IL-15 may affect intestinal homeostasis, we first examined its effects on the generation of inducible regulatory T cells (T reg ) expressing the transcription factor forkhead box P3 (Foxp3). Under physiological conditions, mesenteric lymph node (MLN) dendritic cells drive de novo differentiation of T reg cells [4] [5] [6] . In the presence of IL-15-stimulated MLN dendritic cells, T reg -cell generation from unfractionated CD4
1 T cells (Fig. 1a) or naive CD44 lo CD4 1 T cells ( Supplementary Fig. 1a ) was impaired. Further, IL-15 had no effect on T reg -cell differentiation in the presence of dendritic cells lacking the IL-2-IL-15-receptor-b/c-chain (IL-2-IL-15-Rb/cc) heterodimeric signalling receptor complex 8 ( Supplementary Fig. 2a ) and in dendritic-cell-free systems (Supplementary Figs 1b, 5 ), demonstrating that IL-15 was acting at the level of dendritic cells and not T cells to block T reg generation. To assess the relevance of our in vitro findings, we tested the response to fed chicken ovalbumin (OVA), a model antigen used in oral tolerance experiments, in D d -IL-15 transgenic mice 9 that overexpress IL-15 in the lamina propria and MLN but not in the intestinal epithelium ( Supplementary Fig. 3 ). In agreement with our in vitro observations, the number of naive OT-II RAG1 2/2 CD4 1 T cells converted into T reg cells was significantly reduced in OVA-fed D d -IL-15 transgenic mice compared to wild-type mice (Fig. 1b) . Retinoic acid (RA), which is reported to have a critical role in T reg differentiation [4] [5] [6] , further decreased the conversion of T reg cells in vivo in OVA-fed D d -IL-15 transgenic mice (Fig. 1c) .
To determine the mechanisms by which IL-15-stimulated dendritic cells prevent the conversion of T reg cells and to assess further the role of RA, we used splenic dendritic cells ( Supplementary Fig. 2b ), which, unlike MLN dendritic cells, lack the ability to produce constitutively high levels of RA 4, 6 . Conditioned media obtained from IL-15-treated splenic dendritic cells contained high levels of IL-12p70 and IL-23, but no IL-6 ( Supplementary Fig. 4a ), and decreased T reg -cell conversion ( Supplementary Fig. 2c ). The proinflammatory properties of IL-15 were enhanced further in the presence of RA ( Supplementary Fig. 4a ). As previously reported 10 , IL-12p70 significantly suppressed T reg differentiation at concentrations found in IL-15-conditioned dendritic cell supernatant ( Supplementary Fig. 4b ), and this effect was enhanced by IL-23 in a dose-dependent manner ( Supplementary Fig. 4b ). The requirement for IL-12 in IL-15-mediated suppression of T reg differentiation was demonstrated using IL-12p40-deficient dendritic cells ( Fig. 1d and Supplementary Fig. 4c ) and neutralizing anti-IL-12p40 antibody (Supplementary Fig. 4d) .
Inhibition of T reg -cell conversion in the presence of IL-15 was accompanied by the induction of T H 1 responses in vitro ( Fig. 2a and Supplementary Fig. 6a ) and in vivo in OVA-fed D d -IL-15 transgenic mice ( Fig. 2b and Supplementary Fig. 6c ). As expected, the ability of IL-15 to induce T H 1 responses in vitro (Fig. 2c ) and in vivo (Fig. 2f ) was dependent on IL-12. RA further promoted ( (Fig. 2d and data not shown). Along with RA, these inflammatory mediators then operate at the level of T cells to promote T H 1-cell differentiation and, when IL-6 is present 12 , T H 17-cell differentiation. Although our finding of the adjuvant effect of RA is unexpected within the field of mucosal immunity, it is consistent with its usage as a beneficial proinflammatory adjuvant in anti-tumour immunity 13, 14 . On the basis of our observations indicating that IL-15 and RA act primarily at the level of dendritic cells to disrupt intestinal immune homeostasis, we investigated which signalling pathway was critical for their proinflammatory effects. IL-15 rapidly induced JNK phosphorylation in a dose-dependent manner in dendritic cells (Fig. 3a) . The ability of RA to synergize with IL-15 to promote IL-12p70 (Fig. 3b) and IL-23 ( Supplementary Fig. 8a ) production by dendritic cells and significantly reduce T reg differentiation (Fig. 3c ) was paralleled by its ability to synergize with IL-15 to promote JNK phosphorylation (Fig. 3d) . The co-adjuvant effects of RA were mediated via the RA receptor a (RARa)/JNK signalling pathway (Fig. 3e-g and Supplementary Fig. 8b-d ) and may involve previously reported 15 nongenomic signalling effects of the RAR (Fig. 3h) . We do not exclude the possibility that RA may signal in vivo via an alternative RAR such as RARb, however. Of note, extracellular signal-regulated kinase (ERK; also known as MAPK1) and p38 MAPK (also known as MAPK14) were dispensable ( Supplementary Fig. 8e ).
An intriguing aspect of coeliac disease pathogenesis is how an inflammatory T H 1 response is induced against dietary gluten proteins. Owing to the large number of proline residues they contain, gluten Isotype control
Blocking antibodies -IL-15 transgenic mice were fed OVA and treated with blocking anti-IL12p40, anti-IL-15 and TMb-1 (anti-IL-2Rb) or isotype control monoclonal antibodies. The levels of IL-12p40 in the MLN (f) and IFN-c in lamina propria cells re-stimulated overnight with OVA (g) were quantified. When anti-IL-15 and anti-IL-12 treatment experiments were performed in parallel, control mice received a mixture of corresponding isotype controls. Data represent two pooled experiments (n 5 6 mice per group) except for the anti-IL-12 treatment (n 5 3 individual mice). *P , 0.05, **P , 0.01, ***P , 0.001 (unpaired Student's t-test).
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proteins are resistant to enzymatic degradation, leading to the generation of long peptides that are selectively presented in the gut by HLA-DQ2 or HLA-DQ8 molecules 3 . However, these observations alone fail to explain why 40% of the population expresses the coeliac-disease-associated HLA-DQ2 and HLA-DQ8 molecules, yet induction of gluten-specific inflammatory CD4
1 and CD8 1 T-cell responses 16, 17 occurs in less than 2% of these individuals 3 . In addition, patients with coeliac disease typically develop antibodies to gluten and to the enzyme tissue transglutaminase 2 (TG2; also known as TGM2) 3, 18 . To test the hypothesis that IL-15 overexpressed in the lamina propria may break tolerance to dietary gluten, D d -IL-15 transgenic mice that have levels of IL-15 in the lamina propria comparable to those observed in the lamina propria of coeliac disease patients 7 (compare Supplementary Fig. 3a and Fig. 4e ) and lack IL-15 upregulation in intestinal epithelial cells (IECs) (Supplementary Fig. 3b ), were crossed onto humanized HLA-DQ8 transgenic mice 19 (DQ8-D d -IL-15 transgenic mice). The presence of IFN-c-producing anti-gliadin T cells (Fig. 4a and Supplementary Figs  9a, 10a, b, d , e) in conjunction with anti-gliadin (Fig. 4b) and anti-TG2 (Fig. 4c) antibodies and intraepithelial lymphocytosis (Fig. 4d) 3, 21 . In accordance with human studies 22, 23 , anti-gliadin T H 17 cells were detected only at a very low frequency (Supplementary Figs 9b, c, 10c ). Similar to the observations in OVA-fed D Fig. 11 ) and promoted by RA (Fig. 4a and Supplementary Figs 9a-c, 10 ). Of note, gliadin-fed DQ8 transgenic mice had a slight induction in IFN-c-producing T cells, which may be related to the reported innate effects of gliadin 3 . Supporting the hypothesis that IL-15 may disrupt tolerance to gluten in coeliac disease patients by inducing IL-12, the levels of IL-15 and IL-12p70 were correlated in the lamina propria of active coeliac disease patients (Fig. 4e) . This discovery also gives a functional foundation to the identification of IL-12A as a genetic risk factor for coeliac disease by genome-wide association studies 24 . Our study reveals that in the presence of IL-15, RA has unforeseen co-adjuvant properties that induce T H 1 immunity to fed antigens (Fig. 4f) . It indicates further that under infectious conditions associated with induction of IL-15 and IL-6 in the intestinal mucosa, RA will also promote T H 17 immunity. These observations caution against the use of vitamin A and RA for the treatment of autoimmunity and inflammatory intestinal disorders associated with high levels of IL-15. Indeed, a causal relationship between retinoids used for the treatment of acne and inflammatory bowel disease has been implicated in a subset of patients 25 . Conversely, these findings provide an explanation as to why children suffering from vitamin A deficiency in developing countries 26 respond less efficiently to oral vaccines than children from developed countries 26, 27 , and also indicate that engineering mucosal vaccines that induce IL-15 may be beneficial owing to their ability to induce concomitantly protective IgA antibodies and T H 1 immunity.
More generally, our study supports the concept that there are no 'unconditional' suppressive factors, and that integration of tissue and exogenous signals determine the class of the immune response, which ultimately needs to be tailored to the tissue and the antigen. In line with the idea that the same proinflammatory factors trigger different immunological outcomes depending on the tissue in which they are induced, we found that the ability of IL-12 to inhibit T reg -cell induction was blocked by butyrate, a metabolite produced by commensal bacteria present in the colon but not in the small bowel (data not shown).
One final aspect of our study is that we may have in hand a longawaited physiopathologically relevant murine model mimicking the early stages of coeliac disease. This model is unique in that development 
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of inflammatory anti-gluten immunity develops without microbial adjuvant or systemic immunization in immunologically competent mice with a polyclonal T-cell-receptor repertoire. However, further studies are warranted to establish whether the anti-TG2 antibodies are gluten dependent. Especially relevant to coeliac disease is the identification of IL-15 in the lamina propria as a causative factor driving the differentiation of anti-gluten CD4 1 and CD8 1 T H 1 cells in the intestinal mucosa, resulting in the break of tolerance to gluten. Our observations may also explain why oral tolerance is disrupted in patients with inflammatory bowel disease 28 who also have dysregulated 
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IL-15 expression in the gut 29 . Lastly, our results indicate that inhibiting IL-15 signalling may constitute a therapeutic intervention to restore mucosal tolerance to luminal antigens. . JNK phosphorylation was analysed by western blot following dendritic-cell stimulation with IL-15 and RA. Lamina propria cells were isolated from intestinal biopsies of control and active coeliac disease patients to determine levels of IL-12 and IL-15 expression by ELISA.
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